The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma : a Retrospective Cohort Study

DSpace/Manakin Repository

 
 
See more statistics about this item